Marinus Pharmaceuticals - 株価

MRNS

16.13

毎日の変更:

-0.06%

毎年:

522.78%

価格 日 年
Eisai 7,401.00 66.00 0.90% -7.70%
Acadia Pharmaceuticals 46.94 -2.62 -5.29% 11.82%
Adamas Pharmaceuticals 5.26 0.23 4.57% 32.16%
ALKERMES 19.17 0.02 0.10% -4.34%
Amgen 225.69 -1.35 -0.59% 10.41%
Aptinyx Inc 3.72 0.06 1.64% 17.35%
Arena Pharmaceuticals 76.81 -3.27 -4.08% 63.63%
Biogen 269.85 -3.39 -1.24% -14.54%
Enanta Pharmaceuticals 49.92 0.19 0.38% -4.57%
Esperion Therapeutics 27.76 -0.76 -2.66% -48.54%
Gilead Sciences 63.01 0.55 0.88% -15.09%
Intercept Pharmaceuticals 21.65 -0.03 -0.14% -77.02%
YTE 78.56 -1.07 -1.34% 0.98%
Intra Cellular Therapies 34.44 -0.53 -1.52% 61.54%
Marinus Pharmaceuticals 16.13 -0.01 -0.06% 522.78%
Neurocrine Biosciences 101.42 -8.01 -7.32% 9.56%
Minerva Neurosciences 3.15 0.01 0.32% -59.25%
PTC Therapeutics 57.32 -0.84 -1.44% 10.51%
Regeneron Pharmaceuticals 454.86 -8.19 -1.77% -1.45%
Sarepta Therapeutics 88.93 1.90 2.18% -23.40%
Supernus Pharmaceuticals 24.97 -1.02 -3.92% 36.97%
UCB 83.58 -0.50 -0.59% -6.84%
Vertex Pharmaceuticals 212.06 1.68 0.80% -7.10%
Zogenix 20.43 -0.52 -2.48% -18.02%

価格 日 年
NASDAQ 13358 -230.04 -1.69% 53.83%

MRNS:US
資産
現金と同等
流動資産
流動負債
負債
EBIT
EBITDA
株当たりのEPS利益
自己資本および準備金
借入資本
時価総額
当期純利益
営業経費
営業利益
普通株資本
税引前利益
販売収入
販売および管理費
貿易債権者